Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Anticancer Research|March 4, 2025
Elevated Plasma Interleukin-18 Levels in Head and Neck Squamous Cell Carcinoma: Correlation With IL-18 Binding Protein But Not FerritinJonas Fleckner, Christian Idel, Anke Leichtle, et al.
Anticancer Research|November 29, 2023
Correlation of Intra-tumoral and Peripheral PD-1/PD-L1 Immunity in Head and Neck CancerChristian Idel, Julika Ribbat-Idel, Amelie VON Bernuth, et al.
Frontiers in Medicine|February 15, 2021
Immunologic "Cold" Squamous Cell Carcinomas of the Head and Neck Are Associated With an Unfavorable PrognosisJulika Ribbat-Idel, Sven Perner, Patrick Kuppler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 2, 2009
Phagocytosis of apoptotic cells by neutrophil granulocytes: diminished proinflammatory neutrophil functions in the presence of apoptotic cellsLars Esmann, Christian Idel, Arup Sarkar, et al.
International Journal of Molecular Sciences|August 6, 2020
CDK19 as a Potential HPV-Independent Biomarker for Recurrent Disease in HNSCCFinn-Ole Paulsen, Christian Idel, Julika Ribbat-Idel, et al.
International Journal of Molecular Sciences|August 6, 2020
NR2F6 as a Prognostic Biomarker in HNSCCLuise Klapper, Julika Ribbat-Idel, Patrick Kuppler, et al.
Anticancer Research|March 27, 2024
Different Influence Pattern of Conventional and Alternative Sources of Smoking on Adhesion Molecules and Cytokine Secretion in THP-1 MonocytesTheresa Mohr, Eva Probst, Christian Idel, et al.
Journal of Personalized Medicine|June 24, 2022
TRIM24 Expression as an Independent Biomarker for Prognosis and Tumor Recurrence in HNSCCLuise Klapper, Christian Idel, Patrick Kuppler, et al.
Oncotarget|June 26, 2018
PD-L1 is expressed on human platelets and is affected by immune checkpoint therapyVerena Rolfes, Christian Idel, Ralph Pries, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2015
Eradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point MutationMatthias Leisegang, Boris Engels, Karin Schreiber, et al.
Pageof 6